InSitu Technologies
InSitu Technologies is a global medical device company specializing in minimally invasive intravascular stents and cardiovascular products. With over 25 years of experience, the company focuses on innovative, high-quality devices designed in collaboration with physicians worldwide. Their mission is to extend patients' lives through advanced medical solutions, emphasizing safety, efficacy, and regulatory compliance.
Industries
Nr. of Employees
small (1-50)
InSitu Technologies
539 Phalen Blvd, St Paul, MN 55130, USA
Products
Celosia Covered Stent
A covered coronary stent intended for treatment of vessel perforations in native coronary vessels; features include monolayer graft construction using ePTFE micro-porous polymer, hybrid stent cell design, low pre-mounted crimped profile and optimized radial strength.
Silene Covered Stent
Covered stent indicated for ruptures, dissections, fistulae and aneurysms; includes micro-porous graft material and delivery catheter balloon pillowing technology to aid deployment.
Siro Drug Eluting Stent
Drug-eluting stent platform combining a hybrid cell stent architecture with a drug coating and bioabsorbable polymer intended to limit tissue ingrowth and restenosis; supplied with a rapid-exchange delivery system.
Arriva PTCA Balloon Catheter
Percutaneous transluminal coronary angioplasty (PTCA) balloon catheters engineered with tapered atraumatic tips and materials aimed at improved crossability and navigability in tortuous anatomy.
InSorb Soluble Hemostatic Gauze
A soluble hemostatic gauze formulated with sodium carboxymethyl cellulose that forms a viscous gel on contact with exudate to aid in hemostasis for external and short-term wound management.
InTrac Endoflator (accessory)
Inflation device for interventional procedures with a 20 cc reservoir, 30 ATM rating, luminescent dial and positive locking mechanism.
Celosia Covered Stent
A covered coronary stent intended for treatment of vessel perforations in native coronary vessels; features include monolayer graft construction using ePTFE micro-porous polymer, hybrid stent cell design, low pre-mounted crimped profile and optimized radial strength.
Silene Covered Stent
Covered stent indicated for ruptures, dissections, fistulae and aneurysms; includes micro-porous graft material and delivery catheter balloon pillowing technology to aid deployment.
Siro Drug Eluting Stent
Drug-eluting stent platform combining a hybrid cell stent architecture with a drug coating and bioabsorbable polymer intended to limit tissue ingrowth and restenosis; supplied with a rapid-exchange delivery system.
Arriva PTCA Balloon Catheter
Percutaneous transluminal coronary angioplasty (PTCA) balloon catheters engineered with tapered atraumatic tips and materials aimed at improved crossability and navigability in tortuous anatomy.
InSorb Soluble Hemostatic Gauze
A soluble hemostatic gauze formulated with sodium carboxymethyl cellulose that forms a viscous gel on contact with exudate to aid in hemostasis for external and short-term wound management.
InTrac Endoflator (accessory)
Inflation device for interventional procedures with a 20 cc reservoir, 30 ATM rating, luminescent dial and positive locking mechanism.
Services
Engineering, prototyping and design of coronary, peripheral and airway stents and associated delivery systems.
Precision manufacturing of stents, balloon catheters and cath-lab accessories in an FDA-registered facility.
Commercial licensing and distribution arrangements to support market access across multiple countries.
Engineering, prototyping and design of coronary, peripheral and airway stents and associated delivery systems.
Precision manufacturing of stents, balloon catheters and cath-lab accessories in an FDA-registered facility.
Commercial licensing and distribution arrangements to support market access across multiple countries.
Expertise Areas
- Cardiovascular device design
- Covered stent engineering
- Drug-eluting stent development
- PTCA balloon catheter engineering
Key Technologies
- Expanded PTFE (ePTFE) micro-porous graft materials
- Hybrid open-closed cell stent architecture
- Drug-eluting stent platform with bioabsorbable polymer coatings
- Rapid-exchange delivery systems
News & Updates
Global Network and Experience
InSitu Technologies has partnerships spanning 25 years across six continents, enabling global access to their life-saving devices.
Quality and Innovation Policy
The company is committed to delivering safe, effective, and high-quality intravascular devices, collaborating with physicians worldwide to innovate.
Global Network and Experience
InSitu Technologies has partnerships spanning 25 years across six continents, enabling global access to their life-saving devices.
Quality and Innovation Policy
The company is committed to delivering safe, effective, and high-quality intravascular devices, collaborating with physicians worldwide to innovate.